Daniel Patterson is an experienced professional in pharmaceutical development and chemistry, currently serving as Vice President and Head of CMC, Biologics and Gene Therapies at Roivant Sciences since September 2017. Prior to this role, Daniel held the position of Vice President of Chemistry, Manufacturing and Controls at Cempra Pharmaceuticals and served as a Senior Scientific Investigator at GlaxoSmithKline, focusing on 2nd Generation Product Development and API Chemistry. Daniel's extensive experience in chemical development spans over a decade at GlaxoSmithKline, with roles including Principal Scientist and Investigator. Daniel earned a Ph.D. in Organic Chemistry from Stanford University and a BA in Chemistry from Williams College.
This person is not in the org chart
This person is not in any teams
This person is not in any offices